Hilleman Labs Makeover Rides On New Technology For Heat-stable Rotavirus Vaccines
This article was originally published in PharmAsia News
Executive Summary
The vaccines research JV between Merck and Wellcome Trust has undergone major changes in its operations. The new plan is dramatically different from the one envisioned at the launch of the JV and narrows down on fewer disease areas with a predominant presence in enteric illnesses.